Pre-Cure

growth-positive

The article discusses the advancements in personalized cancer treatment, emphasizing the role of the tumor microenvironment in treatment efficacy. Pre-Cure, a spin-off from Professor Ofra Bennys lab at the Hebrew University of Jerusalem, has developed a versatile organ-on-chip platform. This technology allows for the creation of 3D models of cancerous tissues to test various therapies, aiming to predict the most effective treatment for patients. The platform has been applied to dozens of patients, and upcoming clinical trials will further validate its effectiveness. The technology promises to improve treatment outcomes by providing oncologists with data-driven insights, potentially increasing recovery rates and reducing unnecessary treatments.

growth-positive

Pre-Cure, a pharmaceutical startup spun off from the Hebrew University, is developing a rapid cancer diagnostics platform using advanced microfluidics technology. The platform aims to identify the most effective chemotherapy treatments for patients with solid tumors, significantly reducing the time required to determine treatment efficacy. The company has conducted successful trials in collaboration with Hadassah Medical Center and plans further experiments. Pre-Cure has raised private funding and is seeking additional government and VC funding. The company is also interested in collaborating with scientists and drug development companies. Dan Simhon has recently been appointed as CEO, and the company is working on patenting its technology.

N/A

Eliana Steinberg, a researcher at the Hebrew University, has developed a transparent chip that tests multiple treatments on a single tumor in less than two weeks. The chip, which uses a tiny sample from a cancer tumor, could revolutionize the way cancer patients are treated. The chip is already being used by oncology patients from the Hadassah Hospital. A commercial company will be established on the basis of the development in the coming year. Steinbergs chip belongs to the branch of microfluidics, a field of research that combines engineering, physics, chemistry, microtechnology, and biotechnology.

growth-positive

Israeli company SpacePharma is sending an experiment to the International Space Station (ISS) to test the production of cancer drugs in microgravity. The experiment, which is being launched on a SpaceX Falcon 9 rocket, will carry cancer cells and a pioneering nano-drug called Doxil, developed at the Hebrew University. The aim is to see how the cancer cells and the drug behave in microgravity. If successful, it could lead to more precise cancer treatments being produced in space.

growth-positive

Philips has donated 18 ultrasound units to 13 hospitals in Israel to support the diagnosis and treatment of coronavirus patients. The donation was made possible through the support of HealthIL, an Israeli health innovation community. The ultrasound solutions will be provided to hospitals across Israel to allow direct treatment for coronavirus patients. The donation is part of Philips commitment to support the health system in Israel and work hand in hand to manage the crisis and support patients in need of care.